SPY299.08+3.64 1.23%
DIA250.25+5.37 2.19%
IXIC9,340.22+15.63 0.17%

Morgan Stanley Maintains Equal-Weight on Syndax Pharmaceuticals, Raises Price Target to $22

Morgan Stanley maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Equal-Weight and raises the price target from $10 to $22.

Benzinga · 05/21/2020 12:03

Morgan Stanley maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Equal-Weight and raises the price target from $10 to $22.